Collateralised in accordance with German law

The issuer of the ETCs is BNP Paribas Issuance B.V. Amsterdam, Netherlands, a 100% wholly-owned subsidiary of BNP Paribas S.A.

For all ETCs the issuer provides collateral for 105% of the outstanding volume in accordance with German law. The securities are held in custody exclusively in Germany. The custodian and trustee is Clearstream Banking AG, a 100% wholly-owned subsidiary of Deutsche Börse AG. Clearstream Banking AG monitors the outstanding volume and calls for the necessary amount of collateral. A guarantee for the timely payment of a shortfall is provided through BNP Paribas S.A. Paris, France.

Investors should note that even through collateralisation, the issuer risk cannot be fully mitigated.

Exchange trading on XETRA

The ETCs can be traded on the regulated market of the Frankfurt Stock Exchange on any trading day. Continuous quoting is provided by designated market makers. As with ETFs, a NAV (intrinsic value of the ETC) is published every day.

All product costs in one fee

ETCs from BNP Paribas Arbitrage Issuance B.V. have one management fee, which is displayed on the website. There are no additional fee charges, such as collateral costs. These are already included in the management fee.

About BNP Paribas

BNP Paribas is a global bank with four domestic markets in Europe: Belgium, France, Italy and Luxembourg. It is represented by 185,000 employees in 75 countries worldwide. The BNP Paribas Group has been active in Germany since 1947 and has successfully positioned itself on the market with 13 companies. Private customers, companies and institutions are looked after by roughly 5,000 employees at 19 locations all over the country. The wide-ranging products and services offered by BNP Paribas are almost identical to that of a universal bank.

The debt ratings of BNP Paribas S.A. can be viewed under the following link: https://invest.bnpparibas.com/en/debt-ratings

Risk information

BNP Paribas informs the user of the website that any investment in products presented on the website exposes them to high risks, up to and including the risk of a total loss of the capital invested. Accordingly, these products are not equally suitable for different investors or may not be suitable for investors at all.